Faeth Therapeutics (FTH) awards 30,824 performance-based options
Rhea-AI Filing Summary
Faeth Therapeutics, Inc. granted PAO Josiah Craver a performance-based stock option covering 30,824 shares of common stock at an exercise price of $28.37 per share. The option becomes exercisable only if the average Nasdaq closing price reaches $70.00 over 30 consecutive days and at least one year has passed, and is forfeited if the stock price hurdle is not achieved by the fourth anniversary or not met in connection with a qualifying Change in Control. Following this award, Craver holds 30,824 of these options directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Craver Josiah
Role
PAO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Performance-Based Stock Option (right to buy) F1, F2 | 30,824 | $0.00 | $0.00 |
Holdings After Transaction:
Performance-Based Stock Option (right to buy) — 30,824 shares (Direct)
Footnotes (2)
- F1. Represents a performance-based stock option that becomes exercisable, if at all, on the later of (i) the first date on which the average closing price of the Issuer's common stock on the Nasdaq Stock Market over any 30 consecutive calendar-day period equals or exceeds $70.00 (the "Stock Price Hurdle") and (ii) the first anniversary of the date of grant, in each case subject to the Reporting Person's continued service with the Issuer as of each such date. If the Stock Price Hurdle is not achieved by the fourth anniversary of the date of grant (the "Performance Period"), the option will be forfeited in its entirety.
- F2. In the event of a Change in Control (as defined in the Issuer's 2026 Equity Incentive Plan) of the Issuer prior to the end of the Performance Period, the Stock Price Hurdle will be deemed achieved if the per-share consideration payable in the transaction equals or exceeds $70.00 (subject to equitable adjustment). If so deemed achieved, the option will vest in full immediately prior to the consummation of the Change in Control, subject to the Reporting Person's continued service with the Issuer through such time. If the Stock Price Hurdle is not achieved or deemed achieved in connection with the Change in Control, the option will be forfeited in its entirety.
Key Figures
Performance options granted: 30,824 shares
Exercise price: $28.37 per share
Underlying common shares: 30,824 shares
+3 more
6 metrics
Performance options granted
30,824 shares
Performance-based stock option grant to PAO Josiah Craver
Exercise price
$28.37 per share
Exercise price of the performance-based stock option
Underlying common shares
30,824 shares
Shares of common stock underlying the derivative award
Stock Price Hurdle
$70.00 per share
Average Nasdaq closing price required for vesting
Measurement period for hurdle
30 days
Average closing price measured over 30 consecutive calendar days
Expiration date
2036-07-20
Expiry of the performance-based stock option
Key Terms
Performance-Based Stock Option, Stock Price Hurdle, Change in Control, Equity Incentive Plan
4 terms
Performance-Based Stock Option financial
"Represents a performance-based stock option that becomes exercisable, if at all, on the later"
Stock Price Hurdle financial
"equals or exceeds $70.00 (the "Stock Price Hurdle") and (ii) the first anniversary"
Change in Control financial
"In the event of a Change in Control (as defined in the Issuer's 2026 Equity Incentive"
A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.
Equity Incentive Plan financial
"Change in Control (as defined in the Issuer's 2026 Equity Incentive Plan) of the Issuer"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Faeth Therapeutics (FTH) report for Josiah Craver?
Faeth Therapeutics reported that PAO Josiah Craver received a grant of 30,824 performance-based stock options with an exercise price of $28.37 per share. The options vest only if demanding stock price and service conditions are satisfied, otherwise they are forfeited.
How many Faeth Therapeutics (FTH) performance options were granted to Josiah Craver?
Josiah Craver was granted 30,824 performance-based stock options, each tied to one share of Faeth Therapeutics common stock. After this award, his directly held option position reported in this transaction totals 30,824 derivative securities.
What are the vesting conditions on Josiah Craver’s FTH performance-based options?
The options vest only if Faeth Therapeutics’ stock achieves an average Nasdaq closing price of at least $70.00 over 30 consecutive days and the first anniversary of grant has passed, with continued service. If the hurdle is not achieved by the fourth anniversary, the award is forfeited.
What is the exercise price of Josiah Craver’s Faeth Therapeutics (FTH) options?
The granted performance-based stock options have an exercise price of $28.37 per share. Each option is exercisable, if vesting conditions are met, into one share of Faeth Therapeutics common stock before the stated expiration date in 2036.
When do Josiah Craver’s Faeth Therapeutics performance options expire?
The reported performance-based stock options expire on 2036-07-20. They become exercisable only after the stock price and service requirements are satisfied; if the $70.00 stock price hurdle is never achieved within the performance period, the options are forfeited instead of expiring normally.
How does a Change in Control affect Josiah Craver’s FTH option grant?
If a Change in Control occurs before the performance period ends, the $70.00 Stock Price Hurdle is deemed achieved if per-share consideration equals or exceeds that amount. In that case, the option vests in full immediately before closing, subject to continued service; otherwise it is forfeited.